Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.
Publication
, Journal Article
Daubert, JP; Zareba, W; Rosero, SZ; Budzikowski, A; Robinson, JL; Moss, AJ
Published in: Am Heart J
April 2007
Long QT syndrome (LQTS) is one of several primary electrical disorders or hereditary arrhythmia syndromes along with the short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia. Since its initial recognition in 1957 by Jervell and Lange-Nielsen (Am Heart J. 1957;54:59-68), LQTS has been intimately associated with risk for sudden cardiac death. The implantable defibrillator was developed by Morowski et al (N Engl J Med. 1980;303:322-4) as a treatment to prevent sudden cardiac death. Consequently, implanted cardioverter-defibrillator therapy deserves serious consideration as an important therapy for LQTS.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
April 2007
Volume
153
Issue
4 Suppl
Start / End Page
53 / 58
Location
United States
Related Subject Headings
- Long QT Syndrome
- Humans
- Defibrillators, Implantable
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Daubert, J. P., Zareba, W., Rosero, S. Z., Budzikowski, A., Robinson, J. L., & Moss, A. J. (2007). Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J, 153(4 Suppl), 53–58. https://doi.org/10.1016/j.ahj.2007.01.025
Daubert, James P., Wojciech Zareba, Spencer Z. Rosero, Adam Budzikowski, Jennifer L. Robinson, and Arthur J. Moss. “Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.” Am Heart J 153, no. 4 Suppl (April 2007): 53–58. https://doi.org/10.1016/j.ahj.2007.01.025.
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr;153(4 Suppl):53–8.
Daubert, James P., et al. “Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome.” Am Heart J, vol. 153, no. 4 Suppl, Apr. 2007, pp. 53–58. Pubmed, doi:10.1016/j.ahj.2007.01.025.
Daubert JP, Zareba W, Rosero SZ, Budzikowski A, Robinson JL, Moss AJ. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am Heart J. 2007 Apr;153(4 Suppl):53–58.
Published In
Am Heart J
DOI
EISSN
1097-6744
Publication Date
April 2007
Volume
153
Issue
4 Suppl
Start / End Page
53 / 58
Location
United States
Related Subject Headings
- Long QT Syndrome
- Humans
- Defibrillators, Implantable
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1102 Cardiorespiratory Medicine and Haematology